Glycotest

Glycotest

Visit website
Glycotest

Portfolio company

United States

Sector: Medical Devices & Diagnostics

A liver disease diagnostics company commercialising new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis.

Exclusive, world-wide rights to over 50 patent-protected serum glycoprotein biomarkers that exploit novel sugar-based disease signals.

Tests revolutionise care and treatment for the at-risk, chronic liver disease population.

RELATED NEWS

Easysoftonic

Don’t invest unless you’re prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

X